Reducing Biologic Costs in Psoriasis & Eczema Management
Psoriasis and eczema are driving billions in annual pharmacy costs, largely due to the growing use of biologics. With costs expected to rise further by 2030, health plans and employers need a new approach.
This white paper uncovers key cost drivers, treatment barriers, and innovative solutions to improve outcomes while reducing unnecessary spending.
Reducing Biologic Costs in Psoriasis & Eczema Management
Psoriasis and eczema are driving billions in annual pharmacy costs, largely due to the growing use of biologics. With costs expected to rise further by 2030, health plans and employers need a new approach.
This white paper uncovers key cost drivers, treatment barriers, and innovative solutions to improve outcomes while reducing unnecessary spending.
By submitting the form, I agree to Zest's Terms and Policies.
Let's work together
Partner with Zest Health to implement smarter, more cost-effective psoriasis and eczema care for your workforce, members, or clients. We're here to help you make a difference.
Get in touch